Avinger, Inc. (AVGR)
NASDAQ: AVGR · IEX Real-Time Price · USD
1.430
-0.200 (-12.27%)
At close: Jul 26, 2024, 3:58 PM
1.310
-0.120 (-8.39%)
After-hours: Jul 26, 2024, 6:12 PM EDT
Avinger Market Cap
Avinger has a market cap or net worth of $2.72 million as of July 26, 2024. Its market cap has decreased by -65.55% in one year.
Market Cap
2.72M
Enterprise Value
10.11M
1-Year Change
-65.55%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since January 30, 2015, Avinger's market cap has decreased from $132.80M to $2.72M, a decrease of -97.95%. That is a compound annual growth rate of -33.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 2.70M | -27.03% |
| Dec 29, 2023 | 3.70M | -54.32% |
| Dec 30, 2022 | 8.10M | -81.16% |
| Dec 31, 2021 | 43.00M | 14.97% |
| Dec 31, 2020 | 37.40M | 216.95% |
| Dec 31, 2019 | 11.80M | 68.57% |
| Dec 31, 2018 | 7.00M | 22.81% |
| Dec 29, 2017 | 5.70M | -93.25% |
| Dec 30, 2016 | 84.40M | -70.50% |
| Dec 31, 2015 | 286.10M | 115.44% |
| Jan 30, 2015 | 132.80M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Onconetix | 3.60M |
| Fresh2 Group | 3.56M |
| Tharimmune | 3.37M |
| Venus Concept | 3.37M |
| Protagenic Therapeutics | 3.28M |
| CNS Pharmaceuticals | 3.24M |
| ZyVersa Therapeutics | 3.21M |
| Akanda | 3.14M |